You are here
Progyny Named to the 2018 CNBC Disruptor 50 List
The fertility benefits management company placed #15 and for the second year in a row is among 50 companies that collectively have the potential to upend multibillion-dollar industries
NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) -- Progyny, the leading fertility benefits management company, today announced that it was named #15 on CNBC’s sixth annual Disruptor 50 List and is on the list for the second year in a row.
The CNBC Disruptor 50 is an annual ranked list of the most ambitious and innovative companies representing breakthrough ideas from all over the world. The CNBC Disruptor 50 was selected by CNBC and CNBC.com editorial staff using a proprietary blend of quantitative and qualitative information submitted by the 981 nominated companies. Disruptor 50 data partners PitchBook and IBISWorld provided additional quantitative input. CNBC’s Disruptor 50 Advisory Council, a group of 52 leading thinkers in the field of innovation and entrepreneurship, weighted the quantitative criteria and provided additional analysis of qualitative information.
“We are incredibly honored to be listed for a second year in row. We are growing rapidly as leading employers continue to recognize how they can support their workforces with our innovative fertility benefits solution,” said David Schlanger, CEO of Progyny. “Progyny is a great example that when you are not bound by the traditional practices of big managed care companies and take a focused disease-specific approach to managing care, you can simultaneously deliver better outcomes, an improved patient experience and more efficient use of employer healthcare dollars.”
Progyny partners with leading self-funded employers to help their employees seeking to have a child successfully achieve that dream. Progyny’s fertility benefits solution includes access to treatments such as IVF and egg freezing, support for surrogacy and adoption, an integrated pharmacy program, and clinical and emotional support through Patient Care Advocates (dedicated fertility experts) and digital tools. Progyny’s program delivers superior clinical outcomes, including pregnancy success rates, miscarriage rates and twinning rates that are far better than the national averages. By significantly reducing the rate of twin and triplet births, Progyny is helping to decrease the $26B of medical costs spent annually on preterm birth in the US.
For more information about Progyny, visit www.progyny.com.
For the full list of 2018 CNBC Disruptor 50 companies and methodology, visit CNBC.com/Disruptors.
Progyny is a leading fertility benefits management company that combines clinical and emotional guidance, science, technology and data to provide comprehensive value-based fertility solutions for self-insured employers.
Progyny’s benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. Progyny is privately held and is headquartered in New York, NY. Please visit www.progyny.com.
Media Contact: Selena Yang